The news is by your side.


Tailor-made cancer ‘vaccine’ proves safe: trial results

PARIS: Two experimental treatments for skin cancer, tailor-made to target a particular patient's tumours, proved safe in small-scale trials, their developers reported on Wednesday. The vaccines also triggered an immune response to tumour cells, they said, although this does not necessarily equate to a cure. These are the first drug trials in humans with personalised vaccines directed at neoantigens -- molecules, caused by DNA mutations, found in cancer cells. The results of both were published in the journal Nature.…